Issued Patents All Time
Showing 1–18 of 18 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11932633 | KRas G12C inhibitors | Matthew Arnold Marx, Matthew Lee, James F. Blake, Mark Joseph Chicarelli, Jay Bradford Fell +5 more | 2024-03-19 |
| 11834453 | Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors | Mark Laurence Boys, Bryan Daniel ELLIS, John Gaudino, Ellen Laird, Nicholas Charles LAZZARA +2 more | 2023-12-05 |
| 11634409 | Compounds for the treatment of BRAF-associated diseases and disorders | Patrick Barbour, Katie Keaton BROWN, Adam Cook, Dean Russell Kahn, Ellen Laird +7 more | 2023-04-25 |
| 11414404 | Compounds for the treatment of BRAF-associated diseases and disorders | Patrick Barbour, Katie Keaton BROWN, Adam Cook, Dean Russell Kahn, Ellen Laird +7 more | 2022-08-16 |
| 11267812 | KRAS G12C inhibitors | John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia +10 more | 2022-03-08 |
| 11028093 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors | Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more | 2021-06-08 |
| 10730880 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors | Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more | 2020-08-04 |
| 10669269 | Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors | Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more | 2020-06-02 |
| 10633381 | KRas G12C inhibitors | James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more | 2020-04-28 |
| 10189845 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors | Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more | 2019-01-29 |
| 10125134 | KRas G12C inhibitors | James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more | 2018-11-13 |
| 9809590 | Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors | Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more | 2017-11-07 |
| 9670208 | Serine/threonine kinase inhibitors | James F. Blake, Adam Cook, John Gaudino, Indrani W. Gunawardana, Kevin W. Hunt +11 more | 2017-06-06 |
| 9174981 | Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors | Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more | 2015-11-03 |
| 8987251 | Triazolopyridine compounds as PIM kinase inhibitors | Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Hicks +13 more | 2015-03-24 |
| 8895550 | Triazolopyridine compounds as PIM kinase inhibitors | Shelley Allen, Robert Kirk DeLisle, Julie Marie Hicks, Joseph P. Lyssikatos, Fredrik P. Marmsater +3 more | 2014-11-25 |
| 8575145 | Triazolopyridine compounds as PIM kinase inhibitors | Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Greschuk +13 more | 2013-11-05 |
| 8557809 | Triazolopyridine compounds as PIM kinase inhibitors | Shelley Allen, Robert Kirk DeLisle, Julie Marie Greschuk, Joseph P. Lyssikatos, Fredrik P. Marmsater +3 more | 2013-10-15 |